The Technical Analyst
Conmed Corp [CNMD]
Exchange: NYSE Sector: Healthcare Industry: Medical Devices
Conmed Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.14% $69.40
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 137.57 mill |
| EPS: | 2.61 |
| P/E: | 26.59 |
| Earnings Date: | Jul 24, 2024 |
| SharesOutstanding: | 30.80 mill |
| Avg Daily Volume: | 0.537 mill |
| RATING 2024-05-08 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.72x |
| Company: PE 26.59 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 26.59 | industry: PE -41.13 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$19.06 (-72.53%) $-50.34 |
| Date: 2024-05-08 |
| Expected Trading Range (DAY) |
|---|
|
$ 66.99 - 71.81 ( +/- 3.48%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-05-06 | Aronson Martha Goldberg | Buy | 2 000 | Common Stock |
| 2024-04-30 | Beyer Pat | Buy | 3 000 | Common Stock |
| 2024-04-24 | Beyer Pat | Buy | 20 060 | Options To Purchase Common Stock |
| 2024-03-28 | Garner Todd W | Buy | 227 | Common Stock |
| 2024-03-28 | Cohen Heather L | Buy | 227 | Common Stock |
| INSIDER POWER |
|---|
| 43.63 |
| Last 96 transactions |
| Buy: 443 997 | Sell: 207 624 |
Forecast:
16:00 - $69.36
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $69.36
Forecast 2: 16:00 - $69.36
Forecast 3: 16:00 - $69.36
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $69.40 (-3.14% ) |
| Volume | 0.328 mill |
| Avg. Vol. | 0.537 mill |
| % of Avg. Vol | 61.02 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CNMD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Latest Press Releases
2024-05-01 16:05:00 - Press Release
Conmed Corporation To Present At The Bofa Securities Healthcare Conference
Largo, fla.--(business wire)--conmed corporation (nyse: cnmd) today announced that curt r. hartman, chair of the board, president, and chief executive officer, todd w. garner, executive vice president and chief financial officer, and pat beyer, chief operating officer, will present at the bofa securities healthcare conference at 2:20 p.m. pt (5:20 p.m. et) on tuesday, may 14, 2024 in las vegas, nv. a live audio webcast of the presentation will be accessible through the “investors” section of th.
2024-04-24 16:05:00 - Press Release
Conmed Corporation Promotes Patrick Beyer To Chief Operating Officer
Largo, fla.--(business wire)--conmed corporation (nyse: cnmd) today announced that patrick beyer, president of international and global orthopedics, has been promoted to the newly created role of chief operating officer (coo), effective immediately. in this role, mr. beyer will take on additional responsibility for leading the company's commercial businesses, as well as operations, distribution, regulatory affairs / quality assurance, and customer excellence. “pat has been invaluable in driving.
2024-04-24 16:03:00 - Press Release
Conmed Corporation Announces First Quarter 2024 Financial Results
Largo, fla.--(business wire)--conmed corporation (nyse: cnmd) today announced financial results for the first quarter ended march 31, 2024. first quarter 2024 highlights sales of $312.3 million increased 5.7% year-over-year as reported and 5.9% in constant currency. domestic revenue increased 7.2% year-over-year. international revenue increased 3.8% year-over-year as reported and 4.2% in constant currency. diluted net earnings per share (gaap) were $0.63 compared to diluted net earnings per sha.
2024-04-02 16:05:00 - Press Release
Conmed Corporation To Announce First Quarter 2024 Financial Results On April 24, 2024
Largo, fla.--(business wire)--conmed corporation (nyse: cnmd) today announced that it will report financial results for the first quarter 2024 after the market close on wednesday, april 24, 2024. the company's management will host a conference call at 4:30 p.m. et that same day to discuss the results. to participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. this conference call will also be webcast and can be accessed fro.
2024-01-31 16:05:00 - Press Release
Conmed Corporation Announces Fourth Quarter And Full-year 2023 Financial Results
Largo, fla.--(business wire)--conmed corporation (nyse: cnmd) today announced financial results for the fourth quarter and full-year ended december 31, 2023. fourth quarter 2023 highlights sales of $327.0 million increased 30.4% year over year as reported and 31.5% in constant currency domestic revenue increased 33.3% year over year. international revenue increased 26.5% year over year as reported and 29.0% in constant currency. diluted net earnings per share (gaap) were $1.05 compared to dilut.
Latest News
2024-04-25 13:45:24 - Zacks Investment Research
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
2024-04-25 01:16:09 - Seeking Alpha
CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript
Call End: CONMED Corporation (NYSE:CNMD ) Q1 2024 Earnings Conference Call April 24, 2024, 16:30 PM ET Company Participants Curt Hartman - Chair, President and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Young Li - Jefferies Vik Chopra - Wells Fargo Kristen Stewart - CL King Rick Wise - Stifel Robbie Marcus - J.P. Morgan Travis Steed - BofA Securities Mike Matson - Needham Operator Thank you for standing by and welcome to CONMED's First Quarter Fiscal Year 2024 Earnings Conference Call.
2024-04-24 20:01:57 - Zacks Investment Research
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2024-04-24 18:16:14 - Zacks Investment Research
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Conmed (CNMD) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.66 per share a year ago.
2024-04-03 10:10:15 - Zacks Investment Research
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
2024-04-02 16:05:00 - Business Wire
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.
2024-03-25 18:00:00 - InvestorPlace
3 Retirement Stocks to Buy at a 52-Week Low in March
Despite significant challenges, the U.S. economy has showcased remarkable resilience. Fears of an imminent recession have been allayed by two consecutive quarters of robust GDP growth exceeding 3%.
2024-03-05 08:35:20 - Zacks Investment Research
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
2024-02-02 11:11:03 - Zacks Investment Research
CONMED (CNMD) Misses on Q4 Earnings, Beats Revenue Estimates
CONMED's (CNMD) adjusted fourth-quarter earnings misses while sales beat estimates on the back of strong growth in the United States and international markets. Gross margin improves with a rise in sales.
2024-01-31 21:17:03 - Seeking Alpha
CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript
